Literature DB >> 26995550

Drug Combinations: Tests and Analysis with Isoboles.

Ronald J Tallarida1,2.   

Abstract

Described in this unit are experimental and computational methods to detect and classify drug interactions. In most cases, this relates to two drugs or compounds with overtly similar effects, e.g., two analgesics or two anti-hypertensives. From the dose-response data of the individual drugs, it is possible to generate a curve, the isobole, which defines all dose combinations that are expected to yield a specified effect. The theory underlying the isobole involves the calculation of doses of drug A that are effectively equivalent to doses of drug B with that equivalence determining whether the isobole is linear or nonlinear. In either case, the isobole allows for a comparison with actual combination effects making it possible to determine whether the interaction is synergistic, additive, or sub-additive. Actual as well as illustrative data are employed to demonstrate experimental design and data analysis.
Copyright © 2016 John Wiley & Sons, Inc.

Entities:  

Keywords:  additivity; drug synergism; sub-additivity

Mesh:

Substances:

Year:  2016        PMID: 26995550      PMCID: PMC4839184          DOI: 10.1002/0471141755.ph0919s72

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  16 in total

1.  Antagonisms and antagonists.

Authors:  S LOEWE
Journal:  Pharmacol Rev       Date:  1957-06       Impact factor: 25.468

2.  The problem of synergism and antagonism of combined drugs.

Authors:  S LOEWE
Journal:  Arzneimittelforschung       Date:  1953-06

3.  Isobolographic analysis for combinations of a full and partial agonist: curved isoboles.

Authors:  Yury Grabovsky; Ronald J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2004-06-02       Impact factor: 4.030

Review 4.  Revisiting the isobole and related quantitative methods for assessing drug synergism.

Authors:  Ronald J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2012-04-17       Impact factor: 4.030

5.  The reaction between acetyl choline and muscle cells.

Authors:  A J Clark
Journal:  J Physiol       Date:  1926-08-06       Impact factor: 5.182

6.  Discovery of "self-synergistic" spinal/supraspinal antinociception produced by acetaminophen (paracetamol).

Authors:  R B Raffa; D J Stone; R J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

7.  A study of the interaction of the hypnotic effects and of the toxic effects of chloral hydrate and ethanol.

Authors:  P K Gessner; B E Cabana
Journal:  J Pharmacol Exp Ther       Date:  1970-08       Impact factor: 4.030

8.  A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide.

Authors:  Khalid Benamar; Menachem Yondorf; Joseph J Meissler; Ellen B Geller; Ronald J Tallarida; Toby K Eisenstein; Martin W Adler
Journal:  J Pharmacol Exp Ther       Date:  2006-12-28       Impact factor: 4.030

Review 9.  The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations.

Authors:  Ronald J Tallarida; Robert B Raffa
Journal:  Pharmacol Ther       Date:  2010-05-28       Impact factor: 12.310

10.  Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.

Authors:  T C Chou; P Talalay
Journal:  Adv Enzyme Regul       Date:  1984
View more
  22 in total

1.  Binding site location on GABAA receptors determines whether mixtures of intravenous general anaesthetics interact synergistically or additively in vivo.

Authors:  Daniel E Kent; Pavel Y Savechenkov; Karol S Bruzik; Keith W Miller
Journal:  Br J Pharmacol       Date:  2019-12-11       Impact factor: 8.739

Review 2.  Evaluation of Sweetener Synergy in Humans by Isobole Analyses.

Authors:  M Michelle Reyes; Stephen A Gravina; John E Hayes
Journal:  Chem Senses       Date:  2019-10-17       Impact factor: 3.160

3.  The Actions of Drug Combinations on the GABAA Receptor Manifest as Curvilinear Isoboles of Additivity.

Authors:  Daniel J Shin; Allison L Germann; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2017-08-08       Impact factor: 4.436

Review 4.  Applying the Monod-Wyman-Changeux Allosteric Activation Model to Pseudo-Steady-State Responses from GABAA Receptors.

Authors:  Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2018-10-17       Impact factor: 4.436

5.  Atomoxetine improves memory and other components of executive function in young-adult rats and aged rhesus monkeys.

Authors:  Patrick M Callahan; Marc R Plagenhoef; David T Blake; Alvin V Terry
Journal:  Neuropharmacology       Date:  2019-05-18       Impact factor: 5.250

6.  Additive and subadditive antiallodynic interactions between μ-opioid agonists and N-methyl D-aspartate antagonists in male rhesus monkeys.

Authors:  Jeremy C Cornelissen; Floyd F Steele; Kenner C Rice; Katherine L Nicholson; Matthew L Banks
Journal:  Behav Pharmacol       Date:  2018-02       Impact factor: 2.293

7.  Additive pharmacological interaction between sirtuin inhibitor cambinol and paclitaxel in MCF7 luminal and MDA-MB-231 triple-negative breast cancer cells.

Authors:  Anna Wawruszak; Estera Okon; Ilona Telejko; Arkadiusz Czerwonka; Jarogniew Luszczki
Journal:  Pharmacol Rep       Date:  2022-07-28       Impact factor: 3.919

8.  Antagonistic Pharmacological Interaction between Sirtuin Inhibitor Cambinol and Paclitaxel in Triple-Negative Breast Cancer Cell Lines: An Isobolographic Analysis.

Authors:  Anna Wawruszak; Jarogniew Luszczki; Estera Okon; Arkadiusz Czerwonka; Andrzej Stepulak
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

9.  Synergy between chemical permeation enhancers and drug permeation across the tympanic membrane.

Authors:  Rong Yang; Obiajulu S Okonkwo; David Zurakowski; Daniel S Kohane
Journal:  J Control Release       Date:  2018-06-19       Impact factor: 9.776

10.  Interactions among Lacosamide and Second-Generation Antiepileptic Drugs in the Tonic-Clonic Seizure Model in Mice.

Authors:  Katarzyna Załuska-Ogryzek; Paweł Marzęda; Paula Wróblewska-Łuczka; Magdalena Florek-Łuszczki; Zbigniew Plewa; Hubert Bojar; Dorota Zolkowska; Jarogniew J Łuszczki
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.